http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0205198-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d0f2423f6ee24f92805c4cbccd2ad30
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-972
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563
filingDate 1986-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50626184371f5dd5671d98586f50569e
publicationDate 1986-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0205198-A1
titleOfInvention Immunological complex, its preparation and its use
abstract The invention relates to an immunological complex of two antibodies of a first animal species,. e.g. mouse antibodies, which have been conjugated to form a cyclic tetramer with two monoclonal anti- bodies of a second animal species, e.g. rat monoclonal antibodies, directed against the Fc-fragment of the antibodies of the first animal species. n Preferably, the complex is bifunctional, that is to say, that it contains two different antibodies of the first animal species, one of which is preferably directed to a detectable substance, such as an enzyme, e.g. peroxidase, and the other is directed to any desired antigen. A tetrameric complex of this kind may be used as a labelled antibody in immunoassays. n Further, the invention relates to processes for preparing the complexes and for using the complexes in immunological reactions. Finally, the invention relates to drugs containing a complex according to the invention, as the complexes may be used to direct certain active principles to target cells.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8304195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0389301-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323903-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289003-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289003-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0389301-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108562739-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535894-B2
priorityDate 1985-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0081949-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0096463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8303679-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID316250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127986152

Total number of triples: 34.